Previously, we have reported that high glucose in diabetes led to the up-regulation of AR in tissues both in vitro and in vivo, and that treatment with AR inhibitors prevented hyperglycemia-induced hyperplasia, hyperproliferation of VSMCs, and diabetic cardiomyopathy [141,169,171,172,173]. This evidence concerns the gene AR and diabetic cardiomyopathy.